UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 938

Sortiert nach

Step for breaking free from clinical inertia

Hypertension research, 2022-01, Vol.45 (1), p.5-7

Rakugi, Hiromi

2022

Link zum Volltext

Verfügbarkeit prüfen

Further promotion of "the JSH plan for the future" conscious of new normal after/with COVID-19: message from the new president of the Japanese Society of Hypertension

Hypertension research, 2021-01, Vol.44 (1), p.4-6

Rakugi, Hiromi

2021

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment

Hypertension research, 2021-10, Vol.44 (10), p.1239-1250

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of frailty in Japan: A systematic review and meta-analysis

Journal of epidemiology, 2017-08, Vol.27 (8), p.347-353

2017

Link zum Volltext

Verfügbarkeit prüfen

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

Hypertension research, 2019-09, Vol.42 (9), p.1235-1481

2019

Link zum Volltext

Verfügbarkeit prüfen

Roles of vascular risk factors in the pathogenesis of dementia

Hypertension research, 2020-03, Vol.43 (3), p.162-167

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study

Hypertension research, 2022-05, Vol.45 (5), p.824-833

2022

Link zum Volltext

Verfügbarkeit prüfen

Redefining the elderly as aged 75 years and older: Proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society

Geriatrics & gerontology international, 2017-07, Vol.17 (7), p.1045-1047

2017

Link zum Volltext

Verfügbarkeit prüfen

Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction

Hypertension research, 2021-05, Vol.44 (5), p.489-497

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone

Hypertension research, 2021-04, Vol.44 (4), p.371-385

2021

Link zum Volltext

Verfügbarkeit prüfen

ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19

Clinical science (1979), 2020-11, Vol.134 (22), p.3047

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of esaxerenone on nocturnal blood pressure and natriuretic peptide in different dipping phenotypes

Hypertension research, 2022-01, Vol.45 (1), p.97-105

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study

Journal of human hypertension, 2019-07, Vol.33 (7), p.542-551

2019

Link zum Volltext

Verfügbarkeit prüfen

Source of Chronic Inflammation in Aging

Frontiers in cardiovascular medicine, 2018-02, Vol.5, p.12-12

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension

Hypertension research, 2019-12, Vol.42 (12), p.1932-1941

2019

Link zum Volltext

Verfügbarkeit prüfen

ANRIL: molecular mechanisms and implications in human health

International Journal of Molecular Sciences, 2013-01, Vol.14 (1), p.1278-1292

2013

Link zum Volltext

Verfügbarkeit prüfen

Future Directions of Therapeutic Vaccines for Chronic Diseases

Circulation Journal, 2020/10/23, Vol.84(11), pp.1895-1902

2020

Link zum Volltext

Verfügbarkeit prüfen

Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease

Scientific reports, 2016-05, Vol.6 (1), p.26137-26137, Article 26137

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of esaxerenone (CS-3150), a newly available nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with primary aldosteronism

Hypertension research, 2021-04, Vol.44 (4), p.464-472

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study

Hypertension research, 2019-10, Vol.42 (10), p.1572-1581

2019

Link zum Volltext

Verfügbarkeit prüfen

Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged mice

Hypertension research, 2020-04, Vol.43 (4), p.296-304

2020

Link zum Volltext

Verfügbarkeit prüfen

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

Endocrine-related cancer, 2014-06, Vol.21 (3), p.405-414

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study

American journal of hypertension, 2021-05, Vol.34 (5), p.540-551

2021

Link zum Volltext

Verfügbarkeit prüfen

Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?-Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient mice

Hypertension research, 2023-05, Vol.46 (5), p.1210-1220

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 938

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(787)
Mit Volltextzugriff
(878)

Publikationsform

Sprache

Englisch
(826)
Japanisch
(380)

Erscheinungsjahr

n.n

Thema

Science & Technology
(551)
Life Sciences & Biomedicine
(515)
Humans
(442)
Male
(320)
Cardiovascular System & Cardiology
(241)
Female
(238)
Aged
(229)
Peripheral Vascular Disease
(223)
Middle Aged
(173)
Animals
(159)
Hypertension
(126)
Biological And Medical Sciences
(119)
Medical Sciences
(108)
Adult
(87)
Risk Factors
(85)
Internal Medicine
(83)
Mice
(81)
Aged, 80 And Over
(79)
Hypertension - Drug Therapy
(79)
Physiology
(75)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Step for breaking free from clinical inertia

Further promotion of "the JSH plan for the future" conscious of new normal after/with COVID-19: message from the new president of the Japanese Society of Hypertension

Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment

Prevalence of frailty in Japan: A systematic review and meta-analysis

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

Roles of vascular risk factors in the pathogenesis of dementia

Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study

Redefining the elderly as aged 75 years and older: Proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society

Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction

Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone

ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19

Effect of esaxerenone on nocturnal blood pressure and natriuretic peptide in different dipping phenotypes

Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study

Source of Chronic Inflammation in Aging

Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021

Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension

ANRIL: molecular mechanisms and implications in human health

Future Directions of Therapeutic Vaccines for Chronic Diseases

Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease

Efficacy and safety of esaxerenone (CS-3150), a newly available nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with primary aldosteronism

Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study

Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged mice

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study

Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?-Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient mice

Suchergebnisse filtern